论文部分内容阅读
目的探讨瑞舒伐他汀的药理分析及抗动脉粥样硬化的临床应用价值。方法 110例颈动脉粥样硬化患者,随机分为治疗组和对照组,各55例。治疗组采用瑞舒伐他汀进行治疗,对照组采取阿司匹林进行治疗。观察比较两组患者的临床治疗效果。结果治疗后,治疗组患者各项指标明改善程度明显优于对照组,差异具有统计学意义(P<0.05)。结论瑞舒伐他汀在临床上具有良好的抗炎作用,能够有效地抗血栓及抗氧化,并显著改善患者的内皮功能,促进患者的尽早康复,值得临床推广应用。
Objective To investigate the pharmacological analysis of rosuvastatin and the clinical value of anti-atherosclerosis. Methods 110 patients with carotid atherosclerosis were randomly divided into treatment group and control group, each with 55 cases. The treatment group was treated with rosuvastatin, while the control group was treated with aspirin. The clinical effects of two groups were observed and compared. Results After treatment, the indicators of the treatment group were significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion Rosuvastatin has a good anti-inflammatory effect in clinical practice, which can effectively resist thrombosis and oxidation, and can significantly improve endothelial function and promote early recovery of patients. It is worthy of clinical application.